CVE:ERG 16611 (ERG.V) (ERG) Stock Price, News & Analysis C$0.30 0.00 (0.00%) As of 02/27/2018 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About 16611 (ERG.V) Stock (CVE:ERG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get 16611 (ERG.V) alerts:Sign Up Key Stats Today's RangeC$0.30▼C$0.3050-Day RangeC$0.30▼C$0.3052-Week RangeC$0.22▼C$0.30Volume2,000 shsAverage Volume83,684 shsMarket CapitalizationC$21.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewErgoresearch Ltd. operates in the healthcare sector. The Company manufactures and sells custom foot orthotics and general orthotics, and develops durable medical equipment for the orthopedic market. The Company is engaged in development of orthopedic solutions and products impacting pain management. The Company's products are non-invasive and non-toxic biomechanical devices, which feature patient benefits that are supported by clinical proof and scientific data. The Company designed and commercialized WebFit, a custom-fit orthotics manufacturing software program, and OdrA, an orthotic device. Its range of foot orthotics includes WebFit-Diabetes, WebFit-Gonosteoarthritis and WebFit. Its products also include podo-barometric sensor pads and scanners, and three dimensional (3d) scanner. The Company uses numerical control machine tools to manufacture its foot orthotics. It has approximately 10 laboratories.Read More… Remove Ads Receive ERG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 16611 (ERG.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address ERG Stock News HeadlinesHow can an Employee Resource Group affect your workplace?October 21, 2024 | msn.comERG SpADecember 23, 2023 | reuters.comAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.April 4, 2025 | Paradigm Press (Ad)ERG enters cobalt supply deal with EVelution in USOctober 13, 2023 | msn.comThe state of ERGsAugust 18, 2023 | bizjournals.comMorning EditionApril 11, 2023 | npr.orgAll Things ConsideredApril 11, 2023 | npr.orgWeekend Edition SaturdayApril 9, 2023 | npr.orgSee More Headlines ERG Stock Analysis - Frequently Asked Questions How have ERG shares performed this year? 16611 (ERG.V)'s stock was trading at C$0.30 at the beginning of the year. Since then, ERG shares have increased by 0.0% and is now trading at C$0.30. View the best growth stocks for 2025 here. How do I buy shares of 16611 (ERG.V)? Shares of ERG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Industry, Sector and Symbol Stock ExchangeCVE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolCVE:ERG CIKN/A Webwww.ergoresearch.com Phone+1-514-9313355FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares72,509,000Free FloatN/AMarket CapC$21.39 million OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (CVE:ERG) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 16611 (ERG.V) Please log in to your account or sign up in order to add this asset to your watchlist. Share 16611 (ERG.V) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.